DRAFT BHIVA GUIDELINES Routine monitoring of HIV

28
DRAFT BHIVA GUIDELINES DRAFT BHIVA GUIDELINES Routine monitoring of Routine monitoring of HIV HIV UK-CAB 31 July 2009 Matt Williams writing committee community rep

description

DRAFT BHIVA GUIDELINES Routine monitoring of HIV. UK-CAB 31 July 2009 Matt Williams writing committee community rep. First guideline of this kind Status: (soon-to-be published) draft for consultation Headlines: Long Confirms much current practice Some important new points. - PowerPoint PPT Presentation

Transcript of DRAFT BHIVA GUIDELINES Routine monitoring of HIV

Page 1: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA DRAFT BHIVA GUIDELINESGUIDELINES

Routine monitoring of Routine monitoring of HIVHIV

UK-CAB 31 July 2009

Matt Williams writing committee community rep

Page 2: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

First guideline of this kindStatus: (soon-to-be published) draft for

consultation Headlines:• Long• Confirms much current practice• Some important new points

Page 3: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

Diagnosis recommended confirmed using 4th generation tests (therefore all clinics should have access to 4th generation tests)

Window period: gone…

Page 4: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

4th generation tests can detect HIV before seroconversion

6 week negative results for HIV antibody and antigen with no symptoms = does not have HIV

Page 5: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

Viral load cut-off: clinics must decide lower level for reporting “detectable” result

Is it to be >40 copies/mL? >50? >100? Importance of viral load <50 v >50 notedVL in compartments not generally useful

Page 6: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

Viral load cut-off: some tests are very sensitive and report “mini-spikes” – in the 100s sometimes

No firm recommendation on cut-offClinics need to be aware of nature of, and

ideally choose, viral load tests they usePaper forthcoming…

Page 7: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

CURRENT

CD4 (CD4%) and viral load every 3-4 months generally

Every 6 months sometimesMore often when starting/just started

ARVs or otherwise neededFrequency by mutual agreement

Page 8: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

CD4 – 2 baseline tests (diagnosis and first follow-up visit)?

Page 9: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

CURRENT

Resistance tests as soon as practical after diagnosis (genotype)

Page 10: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

Resistance tests at any viral loadComment on effectiveness of current

assays at viral load <500 copies/mL (often works)

Page 11: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

Formalised comprehensive history at first visit, annual review

Includes asking about mood and cognitionShort form (2 question) format as per

NICE guidelinesQ: should mood and cognition be included

at every clinic visit?

Page 12: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

Baseline assessment includes extensive screening for tropical diseases, including worms, TB, malaria and other infectious/parasitic agents

Debate over measles immunity (current preference not to comment)

Page 13: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

CURRENT

STI screen: baseline and regularly

Page 14: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

CURRENT

Cholesterol and cardiovascular risk assessment: baseline and annual check

Page 15: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

CURRENT

Bone: baseline and annual metabolites (more often if over 50? smoker? on tenofovir)

Vitamin D: noted (no recommendations on value of having a measure of deficiency)

Page 16: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

Bone: DEXA scan as per osteoporosis guidelines for general population at risk

Page 17: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

CURRENT

Liver enzymes: at every visit

Page 18: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

CURRENT

Hepatitis: baseline and annual check (A, B, C)

Hepatitis A and B vaccination: recommended (check immunity)

Page 19: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

CURRENT

Urine protein: recommended (when?)Blood glucose: recommended (when?

alternatives?)Full blood count: annual or more frequentAlbumin: every visitTDM: as required

Page 20: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

Lipdystrophy, lipoatropy, metabolic syndrome, peripheral neuropathy: little comment, refer to (forthcoming) side effects and toxicity guidelines/other treatment guidelines

Page 21: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

Age: wrap-up comment on cardiovascular health, bone density and cognition (no special recommendations since no-one quite knows what to do)

Page 22: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

Phylogenetic testing: comment and overview of science

Recommendation: no routine clinical use

Page 23: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

Phylogenetic testing is a research test used to show infection A relates genetically to infection B (as per criminal cases)

What do people think?

Page 24: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

STARHS (detecting recent infection): recommended as routine

What do people think?

Page 25: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NEW!

Superinfection (reinfection): comment and overview of science

If this occurs, not a useful indicator of a person’s sexual life (ie putting others at risk)

What do people think?

Page 26: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

UNSETTLED

Pregnancy testing for women who may start/are on ARVs: offer?

GP/HCW communicationSome aspects of initial work-upExtra points for late diagnosisAdherence

Page 27: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

NOT COVERED

Patient communicationPeople lost to follow-upConsentPainCancer screening (but no to routine HPV

screening for men)What do people think?

Page 28: DRAFT BHIVA GUIDELINES Routine monitoring of HIV

DRAFT BHIVA GUIDELINESDRAFT BHIVA GUIDELINESRoutine monitoring of HIVRoutine monitoring of HIV

ROADMAP

Draft imminent3 weeks BHIVA/UK-CAB advance

consultation3 weeks general consultationFinal editPublish in time for BHIVA autumn

conference….